Evaluation of Effect of Renal Impairment on the PK of Tenofovir Exalidex
| Status: | Completed |
|---|---|
| Conditions: | Renal Impairment / Chronic Kidney Disease |
| Therapuetic Areas: | Nephrology / Urology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 6/8/2018 |
| Start Date: | September 28, 2017 |
| End Date: | February 20, 2018 |
An Open-Label Study to Investigate the Effect of Renal Impairment on the Pharmacokinectics of Tenofovir Exalidex
This is a Phase 1 study to investigate the effects of Renal Impairment on the
pharmacokinetics of Tenofovir exalidex
pharmacokinetics of Tenofovir exalidex
This is a Phase 1 study to investigate the effects of Renal Impairment (mild, moderate and
severe) on the pharmacokinetics of Tenofovir Exalidex
severe) on the pharmacokinetics of Tenofovir Exalidex
Inclusion Criteria:
- Age: 18 years of age and over
- Capable of giving written informed consent
- Capable of completing study requirements
Exclusion Criteria:
- Positive result for HIV, HBV, or HCV
- History or medical condition which could impact patient safety
- Current or past abuse of alcohol or drugs
- Participation in another clinical trial within the past 30 days
We found this trial at
1
site
5055 South Orange Ave Orlando FL 32909
Orlando, Florida 32806
Orlando, Florida 32806
407-240-7878
Click here to add this to my saved trials
